Previous studies have confirmed that patients with COVID-19 can have abnormal liver function, which is manifested by increased ALT and AST levels and decreased albumin levels, but there are fewer reports of abnormal levels of other indexes (Grazzi et al., 2020). The gene discussed is GPT; the disease is COVID-19.